Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes

Imbalance between oxidative stress burden and antioxidant capacity is implicated in the course of atherosclerosis among type 2 diabetic patients. We addressed the effects of insulin, glucagon-like peptide-1 receptor agonists (GLP1-RA), sodium-glucose cotransporter-2 inhibitors (SGLT-2i), and their c...

Полное описание

Библиографические подробности

Главные авторы:	Vaia Lambadiari, John Thymis, Dimitris Kouretas, Zoi Skaperda, Fotios Tekos, Foteini Kousathana, Aikaterini Kountouri, Konstantinos Balampanis, John Parissis, Ioanna Andreadou, Maria Tsoumani, Christina Chania, Konstantinos Katogiannis, George Dimitriadis, Aristotelis Bamias, Ignatios Ikonomidis
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2021-08-01
Серии:	Antioxidants
Предметы:	glucagon-like peptide-1 receptor agonists sodium-glucose cotransporter-2 inhibitors Malondialdehyde Thiobarbituric Acid Reactive Substances 2,2¢-azino-bis-(3-ethylbenzthiazoline-6-sulphonic acid) radical
Online-ссылка:	https://www.mdpi.com/2076-3921/10/9/1379
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!